An Observational Study to Evaluate the Incidence of MACCE According to Time Interval of Taking Medication in Patients With Acute Coronary Syndrome or Cerebral Infarction Who Received DAPT for the Secondary Prevention and Esomezol Cap for the Prevention of Gastrointestinal Bleeding

Clinical trial NCT05487560 · COMPLETED

Trial details

NCT number: NCT05487560
Sponsor: Hanmi Pharmaceutical Company Limited
Status: COMPLETED
Study type: OBSERVATIONAL

Acute Coronary Syndrome or B Cerebral Infarction Requiring DAPT(Clopidogrel + Aspirin) for at Least 6 Months

Start date: 2019-04-18
Primary completion: 2022-06-22
Enrollment: 4133

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.